WinstonWınston
Back

Deep Value: cash covers more than 100% of the stock price

This company holds roughly $363,799 in cash and investments — more than its entire stock-market value, based on its latest quarterly filing. You're paying very little for the actual business. Sometimes that's a genuine bargain or a takeover target, sometimes it's cheap for a reason. Not a buy signal on its own — always ask why it's this cheap.

Medical Care Technologies logo

Medical Care Technologies

MDCE
56
Medical - Care Facilities · Healthcare
Price
$0.00
+0.00 (+50.00%)
Market Cap
$487,525
Winston Score
56
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Strong
Growth
Weak
Cash Flow
Weak
Stability
Exceptional
Valuation
Good

Share count rising — dilution

+360259.7% over 12y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 902K (2013) → 3.25B (2025)

Winston Score History

The full picture

Medical Care Technologies Inc. (MDCE) is a small company that appears to operate as a shell or early-stage entity within the financial services sector, despite its name suggesting a healthcare focus. Shell companies typically hold assets or serve as vehicles for future business combinations, mergers, or acquisitions rather than selling products or services directly to customers.

The company generates some revenue, reflected in its 50.8% gross margin, but its near-zero market capitalization signals it is very small and likely has minimal active operations. It does not appear to have a well-documented geographic footprint or a clear competitive moat at this stage. The primary risk for investors is the significant uncertainty around what business this company will ultimately become, as shell companies can change direction entirely through a reverse merger or acquisition, making it difficult to evaluate on traditional financial metrics.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
44.8%
Healthy — 44.8% gross margin
Profit after running costs
Operating Margin
24.0%
Excellent — 24.0% operating margin
Return on the money invested
ROCE
23.2%
Exceptional — 23.2% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-5.7%
Shrinking sales (-5.7% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
18%
Weak — only 18% of profit becomes cash
Spare cash per sale
FCF Margin
8.2%
Modest free cash flow (8.2%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.02
Conservative — low debt load (0.02)
Covers its interest
Interest Cover
86.30x
Comfortably covers interest (86.3x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
1.5x
Attractive valuation — P/E 1.5

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial